Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hruby

Showing results (161-170 of 202) with videos related to

Pageof 21
Sort By:
The Journal of Antimicrobial Chemotherapy|January 30, 2015
ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrappingSophie Duraffour, María M Lorenzo, Gudrun Zöller, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2007
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxvirusesDebra C Quenelle, Mark N Prichard, Kathy A Keith, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient miceDouglas W Grosenbach, Aklile Berhanu, David S King, et al.
Plos One|May 3, 2013
Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infectionAdams Amantana, Yali Chen, Shanthakumar R Tyavanagimatt, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2013
Lead optimization of an acylhydrazone scaffold possessing antiviral activity against Lassa virusJames R Burgeson, Dima N Gharaibeh, Amy L Moore, et al.
Antimicrobial Agents and Chemotherapy|May 31, 2012
Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secYKelsi M Sandoz, Steven G Eriksen, Brendan M Jeffrey, et al.
Expert Review of Anti-Infective Therapy|September 4, 2020
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applicationsAndrew T Russo, Douglas W Grosenbach, Jarasvech Chinsangaram, et al.
The New England Journal of Medicine|July 5, 2018
Oral Tecovirimat for the Treatment of SmallpoxDouglas W Grosenbach, Kady Honeychurch, Eric A Rose, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocyclesJames R Burgeson, Amy L Moore, Dima N Gharaibeh, et al.
The Journal of Otolaryngology|August 4, 2005
Guidelines for the treatment of tympanostomy tube otorrheaSam J Daniel, Frederick K Kozak, M Clifford Fabian, et al.
Pageof 21

Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|January 30, 2015
ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrappingSophie Duraffour, María M Lorenzo, Gudrun Zöller, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2007
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxvirusesDebra C Quenelle, Mark N Prichard, Kathy A Keith, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient miceDouglas W Grosenbach, Aklile Berhanu, David S King, et al.
Plos One|May 3, 2013
Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infectionAdams Amantana, Yali Chen, Shanthakumar R Tyavanagimatt, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2013
Lead optimization of an acylhydrazone scaffold possessing antiviral activity against Lassa virusJames R Burgeson, Dima N Gharaibeh, Amy L Moore, et al.
Antimicrobial Agents and Chemotherapy|May 31, 2012
Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secYKelsi M Sandoz, Steven G Eriksen, Brendan M Jeffrey, et al.
Expert Review of Anti-Infective Therapy|September 4, 2020
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applicationsAndrew T Russo, Douglas W Grosenbach, Jarasvech Chinsangaram, et al.
The New England Journal of Medicine|July 5, 2018
Oral Tecovirimat for the Treatment of SmallpoxDouglas W Grosenbach, Kady Honeychurch, Eric A Rose, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocyclesJames R Burgeson, Amy L Moore, Dima N Gharaibeh, et al.
The Journal of Otolaryngology|August 4, 2005
Guidelines for the treatment of tympanostomy tube otorrheaSam J Daniel, Frederick K Kozak, M Clifford Fabian, et al.
Pageof 21